Bandingkan Harga & Kinerja Equity Development Investment Tbk. (GSMF) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Equity Development Investment Tbk. dan Organon Pharma Indonesia Tbk.: Equity Development Investment Tbk. diperdagangkan di Rp106 (kapitalisasi pasar 1,92 T, volume 24 jam 294,19 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Equity Development Investment Tbk. jauh lebih besar — sekitar 18,4× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| GSMF | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 1,92 T | 104,4 M |
Volume | 294,19 jt | — |
Lot | 2,94 jt | — |
Perputaran | 36,95 M | — |
Harga Rata-rata | 125,58 | — |
Nilai Transaksi | 36,95 M | — |
Harga Ekuilibrium Indikatif | 106 | — |
Volume Ekuilibrium Indikatif | 8,47 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Equity Development Investment Tbk.
PT Equity Development Investment Tbk (the “Company”) was established in Jakarta under the name of PT Gajah Surya Arta Leasing on November 1, 1982 based on the Notarial Deed of Didi Sudjadi, S.H., No. 1, as amended by deed No. 30 dated March 6, 1985 of the same notary. The Company changed its name to be PT BDNI Capital Corporation Tbk. On February 7, 2001, it changed the named again to be PT GT Investama Kapital, Tbk.
Selengkapnya di halaman GSMF →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
